evenfolioETF Details
iShares·Health·IDNA · NYSE Arca
iShares Genomics Immunology and Healthcare ETF (IDNA)
- Price
- $42.76
- —30 Oct 2026
- Assets
- $299M
- Total net assets
- Expense ratio
- 0.47%
- Category 1.00%
- Yield
- 0.66%
- Trailing distributions
- 1Y return
- 71.4%+42.6%
- Category 28.8%
- 3Y CAGR
- 35.6%+14.1%
- Category 21.5%
- 5Y CAGR
- -2.0%-6.2%
- Category 4.1%
Loading NAV history…
iShares Genomics Immunology and Healthcare ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +1.0% | +32.3% | +46.5% | +64.0% | +71.4% | +35.6% | -2.0% | — | +8.7% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -2.6% | +22.4% | +23.4% | +43.5% | +42.6% | +14.1% | -6.2% | — | -3.0% |
Holdings
The 10 largest positions make up 48.4% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| MRNA | Moderna Inc | 11.20% |
| TWST | Twist Bioscience Corp | 7.70% |
| IOVA | Iovance Biotherapeutics Inc | 4.98% |
| GMAB.CO | Genmab AS | 3.98% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 3.80% |
| BAYN.DE | Bayer AG | 3.60% |
| MRK | Merck & Co Inc | 3.32% |
| 4502.T | Takeda Pharmaceutical Co Ltd | 3.30% |
| REGN | Regeneron Pharmaceuticals Inc | 3.29% |
| INCY | Incyte Corp | 3.27% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 3.7
- P/S
- 5.4
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.7%
- Cash0.3%
ETF details
- Issuer
- iShares
- Category
- Equity · Health
- Ticker
- IDNA
- Exchange
- NYSE Arca
- Inception
- 11 Jun 2019 (7.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.47% (category 1.00%)
- Holdings turnover
- 49% (category 51%)
- Distribution yield
- 0.66%
- Beta, 3 years
- 1.01
- Total net assets
- $299M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XHS · State Street SPDR S&P Health Care Services ETFState Street Investment Management · $218.5M · ER 0.35%5Y 6.4%
- SBIO · ALPS Medical Breakthroughs ETFALPS · $211.6M · ER 0.50%5Y 4.3%
- CANC · Tema Oncology ETFTema ETFs · $208.6M · ER 0.75%
- XHE · State Street SPDR S&P Health Care Equipment ETFState Street Investment Management · $185.7M · ER 0.35%5Y -6.2%
- PSCH · Invesco S&P SmallCap Health Care ETFInvesco · $178.5M · ER 0.29%5Y -1.7%
- BBP · Virtus Biotech ETFVirtus · $131.5M · ER 0.34%5Y 15.0%